Model compound 2. Using 1-methyltryptophan methyl ester
hydrochloride instead of tryptophan methyl ester 9, the same
procedure as with synthesizing compound 1 was performed, and
two diastereomers 2a (24 mg, 19%) and 2b (19 mg, 15%) were
125.9, 127.0, 128.4, 136.1, 139.5, 151.2 (NCONH), 167.4 (COO),
170.2 (NHCO), 171.9 (CH2CONH); TOFMS (EI) calcd for (M+)
C26H26N4O6: 490.1852, found 490.1833.
obtained as white powders. 2a: mp 162–164 ◦C. mmax(KBr)/cm−1
=
1-(Carboxymethyl)thymine tryptophan methyl ester amide 4. 1-
(Carboxymethyl)thymine 6 (230 mg, 1.25 mmol) and an excess
of BOP (608 mg, 1.37 mmol) were dissolved in DMF (6 mL)
and stirred at room temperature for 30 min, and a solution of
tryptophan methyl ester 9 (272 mg, 1.25 mmol) in DMF (2 mL)
was added, and stirred for 5 h at room temperature. The reaction
mixture was purified by column chromatography on aluminium
oxide (100–200 mesh, ethyl acetate–methanol 20 : 1 → 3 : 1)
to give 4 as a white powder (134 mg, 28%). Mp 207–209 ◦C.
mmax(KBr)/cm−1 = 3351s, 3311w, 1730s, 1688s, 1646s, 1354w,
1701s, 1475m, 1282m, 1213m; 1H NMR (300 MHz, CDCl3, TMS):
d = 1.56 (s, 3H, CH3), 3.35 (m, 3H, CHCH2 + NCH2), 3.70 (s,
3H, NCH3), 3.75 (s, 3H, OCH3), 4.43 (d, 1H, NCH2), 4.73 (s,
1H, NCH), 4.88 (m, 1H, CHCH2), 6.29 (d, 1H, NHCH), 6.84
(s, 1H, Hindole), 7.04–7.36 (m, 14H, ArH + Hindole); 13C NMR
(75 MHz, CDCl3): d = 23.3 (CH3), 27.3 (CHCH2), 32.8 (NCH3),
49.1 (NCH2), 52.7 (OCH3), 53.4 (NHCH), 66.2 (NCH), 76.5
(CCH3), 91.3 (OC), 107.9, 109.6, 118.6, 119.5, 122.1, 125.5, 126.1,
127.9, 128.2, 128.3, 128.4, 128.6, 128.8, 137.1, 138.8, 143.8, 151.0
(NCONH), 167.0 (COO), 169.4 (NHCO), 172.1 (CH2CONH);
TOFMS (CI) calcd for (M + 1)+ C33H32N4O6: 581.2400, found
581.2398. 2b: mp 120–122 ◦C. mmax(KBr)/cm−1 = 1709s, 1469m;
1H NMR (300 MHz, CDCl3, TMS): d = 1.38 (s, 3H, CH3), 3.31
(m, 3H, CHCH2 + NCH2), 3.71 (s, 6H, NCH3 + OCH3), 4.57 (d,
1H, NCH2), 4.86 (s, 1H, NCH), 4.89 (m, 1H, CHCH2), 6.35 (d, 1H,
NHCH), 6.79 (s, 1H, Hindole), 7.06–7.46 (m, 14H, ArH + Hindole);
13C NMR (75 MHz, CDCl3): d = 22.9 (CH3), 26.9 (CHCH2),
32.9 (NCH3), 49.0 (NCH2), 52.7 (OCH3), 53.1 (NHCH), 65.3
(NCH), 76.3 (CCH3), 91.3 (OC), 107.8, 109.8, 118.3, 119.8, 122.3,
125.5, 126.1, 127.7, 128.1, 128.3, 128.5, 128.6, 128.8, 137.1, 138.5,
143.6, 150.7 (NCONH), 167.3 (COO), 169.0 (NHCO), 171.9
(CH2CONH); TOFMS (EI) calcd for (M+) C33H32N4O6: 580.2322,
found 580.2319.
1
1221m; H NMR (300 MHz, [D6]DMSO, TMS): d = 1.73 (s,
3H, CH3), 3.09 (m, 2H, CHCH2), 3.57 (s, 3H, OCH3), 4.34 (m,
2H, NCH2), 4.53 (m, 1H, CHCH2), 6.97–7.50 (m, 6H, NCH +
Hindole), 8.68 (d, 1H, NHCH), 10.89 (s, 1H, NHindole), 11.26 (s,
1H, CNHC); 13C NMR (75 MHz, [D6]DMSO): d = 11.9 (CH3),
27.3 (CHCH2), 49.0 (NCH2), 51.9 (OCH3), 53.4 (NHCH), 108.0,
109.1, 111.5, 118.0, 118.5, 121.0, 123.7, 127.1, 136.0, 142.3, 150.9
(NCONH), 164.4 (COO), 167.1 (NHCO), 172.0 (CH2CONH);
TOFMS (CI) calcd for (M + 1)+ C19H20N4O5: 385.1512, found
385.1518.
1-(Carboxymethyl)thymine (1-methyltryptophan) methyl ester
amide 5. The same procedure as with the synthesis of 4 was
performed with 1-methyltryptophan methyl ester hydrochloride
and triethylamine instead of 9, and 5 was obtained as a white
powder (300 mg, 60%). Mp 196–198 ◦C. mmax(KBr)/cm−1 = 3435m,
1
Model compound 3. Sodium hydroxide (30 mg) and oxetane 8b
(190 mg, 0.5 mmol) were added to a solution of water (10 mL) and
methanol (10 mL), and stirred for 2 h at room temperature. The
reaction mixture was diluted with 100 mL of water and extracted
twice with 100 mL of ethyl acetate. Diluted hydrochloric acid
was dropped into the water layer to adjust the pH to 3. The
solution was extracted twice with 100 mL of ethyl acetate. The
organic phase was washed with water, dried with MgSO4, filtered
and concentrated in vacuo. Then a solution of TBTU (321 mg,
1.0 mmol) and HOBt (68 mg, 0.5 mmol) in 8 mL of DMF was
added. The reaction mixture was stirred for 30 min. After the
addition of a solution of tryptophan methyl ester 9 (131 mg,
0.6 mmol) in DMF (2 mL), the reaction mixture was stirred
for 8 h at room temperature. Then it was diluted with 100 mL
of water and extracted twice with 100 mL of ethyl acetate. The
combined organic layers were dried with MgSO4, filtered and
concentrated in vacuo. The residual crude product was purified
by silica gel column chromatography (gel-H, CHCl3–methanol
100 : 1). Two diastereomers were obtained, and the less polar
isomer 3◦as white powder (26 mg, 11%) was characterized. Mp
1740m, 1690s, 1666m, 1470w; H NMR (300 MHz, [D6]DMSO,
TMS): d = 1.74 (s, 3H, CH3), 3.09 (m, 2H, CHCH2), 3.58 (s,
3H, NCH3), 3.73 (s, 3H, OCH3), 4.33 (s, 2H, NCH2), 4.53 (m,
1H, CHCH2), 7.01–7.51 (m, 6H, NCH + Hindole), 8.67 (d, 1H,
NHCH), 11.26 (s, 1H, NH); 13C NMR (75 MHz, [D6]DMSO):
d = 11.8 (CH3), 27.0 (NCH3), 32.3 (CHCH2), 49.0 (NCH2), 51.8
(OCH3), 53.2 (NHCH), 107.9, 108.4, 109.6, 118.2, 118.5, 121.1,
127.4, 128.2, 136.5, 142.2, 150.8 (NCONH), 164.3 (COO), 167.0
(NHCO), 171.8 (CH2CONH); TOFMS (CI) calcd for (M + 1)+
C20H22N4O5: 399.1668, found 399.1667.
Acknowledgements
The authors are grateful for the financial support by the National
Natural Science Foundation of China (Grant no. 30470444,
20332020).
References
1
249–251 C. mmax(KBr)/cm−1 = 3392s, 1702s, 1478m, 1283m; H
1 J. Cadet and P. Vigny, in The Photochemistry of Nucleic Acids,
Bioorganic Photochemistry, ed. H. Morrison, Wiley Interscience, New
York, 1990, vol. 1, pp. 1–272; E. C. Friedberg, G. C. Walker and W.
Siede, DNA Repair and Mutagenesis, ASM Press, Washington DC,
1995; J.-S. Taylor, Pure Appl. Chem., 1995, 67, 183; J. Cadet, M. Berger,
T. Douki, B. Morin, S. Raoul, J.-L. Ravanat and S. Spinelli, J. Biol.
Chem., 1997, 378, 1275.
NMR (300 MHz, [D6]DMSO, TMS): d = 1.62 (s, 3H, CH3), 3.09
(m, 2H, CHCH2), 3.53 (s, 3H, OCH3), 3.85 (m, 2H, NCH2), 4.12
(d, J = 6.5 Hz, 1H, NCH), 4.49 (m, 1H, NHCH), 5.65 (d, J =
6.5 Hz, 1H, OCH), 6.91–7.09 (m, 3H, Hindole), 7.32–7.46 (m, 7H,
Hindole + benzene), 8.44 (d, 1H, NHCH), 10.87 (s, 1H, CNHC); 13C
NMR (75 MHz, [D6]DMSO): d = 22.4 (CH3), 27.0 (CHCH2),
48.8 (NCH2), 51.7 (OCH3), 53.2 (NHCH), 64.4 (NCH), 77.0
(CCH3), 85.2 (OCH), 109.1, 111.3, 117.9, 118.4, 120.9, 123.5,
2 A. Sancar, Chem. Rev., 2003, 103, 2203.
3 P. E. M. Gibbs, B. J. Kilbey, S. K. Banerjee and C. W. Lawrence,
J. Bacteriol., 1993, 175, 2607; J.-S. Taylor, Acc. Chem. Res., 1994, 27,
76.
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 291–298 | 297
©